An anti-Aspergillus protein from Escherichia coli DH5α: Putative inhibitor of siderophore biosynthesis in Aspergillus fumigatus

Mycoses

Volumn 57, Issue 3, 2014, Pages 153-162

  Balhara, Meenakshi ^a   Ruhil, Sonam ^a   Kumar, Manish ^a   Dhankhar, Sandeep ^a   Chhillar, A K ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Anti aspergillus protein (AAP); CAS assay; Escherichia coli; Non ribosomal peptide synthetase (NRPS); Siderophore

Indexed keywords

ANTI ASPERGILLUS PROTEIN; ANTIFUNGAL AGENT; DODECYL SULFATE SODIUM; NONRIBOSOMAL PEPTIDE SYNTHETASE; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL STRAIN; BIOSYNTHESIS; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; ERYTHROCYTE; ESCHERICHIA COLI; FUNGUS ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SPORE GERMINATION; TOXICITY TESTING; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANTI-ASPERGILLUS PROTEIN (AAP); CAS ASSAY; ESCHERICHIA COLI; NON-RIBOSOMAL PEPTIDE SYNTHETASE (NRPS); SIDEROPHORE;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; COMPUTATIONAL BIOLOGY; ERYTHROCYTES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PROTEOMICS; SIDEROPHORES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84893807980     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12119     Document Type: Article

References (28)

1. Pfaller AM, Pappas GP, Wingard RJ. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43: S3-14.
2. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32: 1319-24.
3. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy 2007; 27: 369-85.
4. Wagner C, Graninger W, Presterl E. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology 2006; 78: 161-77.
5. Lass-Flörl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs 2011; 71: 2405-19.
6. Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 2012; 67: 362-6.
7. Arikan-Akdagli S. Azole resistance in Aspergillus: global status in Europe and Asia. Ann N Y Acad Sci 2012; 1272: 9-14.
8. Badali H, Vaezi A, Haghani I et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses 2013; doi:10.1111/myc.12089
9. Gubbins PO, Penzak SR, Polston S, McConnell SA, Anaissie E. Characterizing and predicting amphotericin B-associated nephotoxicity in bone marrow or peripheral blood stem cell transplant recipients. Pharmacotherapy 2002; 22: 961-74.
10. Vicente MF, Basilo A, Cabello A, Pelaez F. Microbial natural products as a source of antifungals. Clin Microbiol Infect 2003; 9: 15-32.
11. Selitrennikoff PC. Antifungal Proteins. Appl Environ Microbiol 2001; 67: 2883-94.
12. Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol 2005; 56: 845-57.
13. Lebbadi M, Galvez A, Maqueda M, Martinez-Bueno M, Valdivia E. Fungicin M-4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4. J Appl Bacteriol 1994; 77: 49-53.
14. Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab 2009; 10: 68-78.
15. Chhillar AK, Arya P, Mukherjee C et al. Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones:novel compounds against Aspergillosis. Bioorg Med Chem 2006; 14: 973-81.
16. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. DNA packaging events. J Mol Biol 1973; 80: 575-99.
17. Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987; 8: 93-99.
18. CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, document M38-A2.Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
19. Latoud CF, Peypoux G, Genet MR, Morgat JL. Interactions of antibiotics of the iturin group with human erythrocytes. Biochim Biophys Acta 1986; 56: 526-35.
20. Gao WD, Cao HT, Ji RH, Zhang ZC. Isolation and characterization of protein-biosynthesis inhibiting proteins from seeds of luffa cylindrica. Acta Biochim Biophys 1994; 26: 289-95.
21. Schwyn B, Neilands JB. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987; 160: 47-56.
22. Brakhage AA. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Curr Drug Targets 2005; 6: 875-86.
23. Loeffler J, Stevens AD. Antifungal drug resistance. Clin Infect Dis 2003; 36: S31-41.
24. Liu Y, Chen Z, Ng TB et al. Bacisubin, an antifungal protein with ribonuclease and hemagglutinating activities from Bacillus subtilis strain B-916. Peptides 2007; 28: 553-9.
25. Sorensen K, Kim KH, Takemoto JY. In vitro antifungal and fungicidal activities and erythrocytes toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae. Antimicrob Agents Chemother 1996; 40: 2710-3.
26. Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 2007; 71: 413-51.
27. 5-oxygenase, is required for virulence. Infect Immun 2005; 73: 5493-503.
28. Schettl M, Bignell E, Kragl C et al. Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathog 2007; 3: e128; doi:10.1371/journal.ppat.0030128.